+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Lurasidone Hydrochloride Generics Market - Global Forecast 2026-2032- Product Image
Lurasidone Hydrochloride Generics Market - Global Forecast 2026-2032- Product Image
Sale

Lurasidone Hydrochloride Generics Market - Global Forecast 2026-2032

  • Report

  • 196 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6125707
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Lurasidone Hydrochloride Generics Market is projected to reach USD 985.24 Million in 2026. It is expected to continue growing at a CAGR of 10.83%, reaching USD 1.84 Billion by 2032.

Lurasidone Hydrochloride Generics: Executive Overview

Lurasidone hydrochloride is an atypical antipsychotic used primarily in the management of schizophrenia and bipolar depression. Generic availability is shaped by regulatory authorization, patent and exclusivity conditions, manufacturing capability, procurement practices, and clinicians’ confidence in therapeutic equivalence. Demand is also influenced by the need for treatments that address psychiatric symptoms while limiting metabolic and other tolerability concerns. This executive summary examines the structural forces affecting the generic segment without presenting market estimates, shares, or forecasts.

Regulatory Access and Competitive Dynamics Are Reshaping the Landscape

The landscape is being transformed by the transition from originator products to approved generics, more rigorous bioequivalence expectations, and purchasing systems that increasingly emphasize documented quality and continuity of supply. Developers must navigate country-specific filing requirements, inspection standards, pharmacovigilance obligations, and reimbursement rules. Formulation development, reliable active-ingredient sourcing, packaging compliance, and the ability to manage launch timing are central to sustainable participation. Hospitals and public purchasers are also placing greater weight on supply resilience rather than lowest price alone.

Artificial Intelligence Is Strengthening Development, Quality, and Supply Decisions

Artificial intelligence can support generic development by helping teams prioritize formulation variables, analyze dissolution and stability data, identify manufacturing-process deviations, and improve demand and inventory planning. In quality operations, machine-learning tools may assist document review, anomaly detection, and signal identification within pharmacovigilance databases, provided that outputs remain subject to validated controls and human oversight. Adoption is constrained by data quality, model explainability, cybersecurity, privacy, and regulatory expectations for computerized systems. AI therefore acts as an enabling layer rather than a substitute for bioequivalence studies, clinical judgment, quality systems, or regulatory accountability.

Regional Insights: Access Conditions Differ Across Six Major Geographies

North America combines mature generic-substitution practices with stringent regulatory, manufacturing, and supply-chain requirements. Europe emphasizes centralized quality principles alongside national reimbursement and procurement systems, while the European Union supports harmonized regulatory processes but retains country-level commercial differences. Asia-Pacific is supported by large patient populations, expanding pharmaceutical manufacturing, and varied regulatory maturity, with Japan, China, India, South Korea, and Australia requiring distinct access strategies. Latin America remains highly dependent on national registration, public procurement, and affordability mechanisms. The Middle East is influenced by centralized purchasing, import reliance, and national localization priorities, while Africa presents diverse regulatory environments, constrained distribution infrastructure, and a strong need for dependable essential-medicine supply.

Group Insights: Trade and Policy Blocs Shape Generic Access

ASEAN markets differ in registration pathways, reimbursement structures, and reliance on imported medicines, making regional coordination valuable but insufficient on its own. BRICS members combine substantial pharmaceutical demand with varied regulatory systems, domestic-production policies, and public-sector purchasing models. The European Union benefits from shared regulatory frameworks, although pricing, reimbursement, and tender decisions remain nationally determined. G7 markets generally apply demanding quality standards and sophisticated pharmacovigilance expectations, with access shaped by payer and procurement policies. GCC countries often use coordinated procurement and maintain strong dependence on qualified international supply. NATO membership does not create a single pharmaceutical market, but its members’ resilience and security priorities can influence contingency planning, stock strategies, and sourcing decisions.

Country Insights: National Regulation and Reimbursement Remain Decisive

Australia emphasizes centralized evaluation and public reimbursement processes, while Brazil combines federal regulation with public purchasing and private-market channels. Canada’s provincial and territorial reimbursement decisions create variation in access, and China continues to place importance on domestic manufacturing, centralized procurement, and evolving regulatory standards. France, Germany, Italy, and Spain operate within the European framework but differ in pricing, substitution, tendering, and reimbursement practices. India is a major pharmaceutical manufacturing base with a complex state and national purchasing environment. Japan applies detailed quality and reimbursement requirements; Mexico combines national regulatory oversight with public-sector procurement. Russia’s access environment is shaped by domestic-production priorities and changing trade conditions. South Korea uses a highly regulated reimbursement system. The United Kingdom applies rigorous national authorization and health-technology processes. The United States combines federal approval requirements with payer, pharmacy-benefit, and contracting dynamics.

Industry Leaders Should Prioritize Resilience, Evidence, and Market-Specific Execution

Leaders should build a country-by-country access plan that aligns regulatory submissions, reimbursement evidence, procurement requirements, and launch sequencing. They should qualify multiple sources for critical materials where feasible, maintain robust supplier oversight, and use scenario planning for shortages, inspections, logistics disruptions, and policy changes. Product strategy should emphasize validated quality, consistent dissolution and stability performance, patient- and pharmacy-friendly packaging, and clear medical-information support. AI investments should focus first on controlled, auditable use cases in quality, supply planning, and safety surveillance. Finally, organizations should strengthen engagement with regulators, payers, hospital systems, pharmacists, and patient-support stakeholders while monitoring substitution rules and treatment-continuity risks.

Research Methodology: Regulatory, Clinical, Commercial, and Supply-Chain Triangulation

This summary uses a structured qualitative framework for the lurasidone hydrochloride generics segment. The assessment considers the medicine’s therapeutic role, generic-development requirements, regulatory and pharmacovigilance expectations, reimbursement and procurement mechanisms, manufacturing and distribution conditions, digital transformation, and regional policy differences. Geographic interpretation covers North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific, with additional comparison across ASEAN, BRICS, the European Union, G7, GCC, and NATO groupings and the specified countries. Conclusions are framed as verified structural insights and deliberately exclude market estimates, market sizing, market shares, forecasts, and unsupported company-specific claims.

Conclusion: Reliable Access Will Depend on Quality and Execution

The generic lurasidone hydrochloride landscape is shaped less by a single global model than by the interaction of regulatory authorization, therapeutic confidence, reimbursement, procurement, and supply reliability. Participants that combine rigorous quality systems with geographically informed access strategies will be better positioned to support continuity of treatment. The strongest operating model is likely to pair disciplined generic development with resilient sourcing, transparent evidence, responsible AI adoption, and close monitoring of national policy changes. These priorities can improve preparedness while maintaining appropriate standards for patient safety and regulatory compliance.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Lurasidone Hydrochloride Generics Market, by Form
7.1. Introduction
7.2. Orally Disintegrating Tablet
7.3. Tablet
8. Lurasidone Hydrochloride Generics Market, by Strength
8.1. Introduction
8.2. 20 mg
8.3. 40 mg
8.4. 60 mg
8.5. 80 mg
9. Lurasidone Hydrochloride Generics Market, by Packaging Type
9.1. Introduction
9.2. Blister
9.3. Bottle
10. Lurasidone Hydrochloride Generics Market, by Application
10.1. Introduction
10.2. Bipolar Depression
10.3. Major Depressive Disorder
10.4. Schizophrenia
11. Lurasidone Hydrochloride Generics Market, by Distribution Channel
11.1. Introduction
11.2. Offline
11.3. Online
12. Lurasidone Hydrochloride Generics Market, by End User
12.1. Introduction
12.2. Clinics
12.3. Home Care Settings
12.4. Hospitals
13. Lurasidone Hydrochloride Generics Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Lurasidone Hydrochloride Generics Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Lurasidone Hydrochloride Generics Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Accord Healthcare
17.2. Alembic Pharmaceuticals
17.3. Alkem Laboratories
17.4. Amneal Pharmaceuticals
17.5. Annora Pharma
17.6. Aurobindo Pharma
17.7. Camber Pharmaceuticals
17.8. Chartwell Rx
17.9. Cipla
17.10. Dr. Reddy's Laboratories
17.11. Emcure Pharmaceuticals
17.12. Heritage Pharma Avet
17.13. Icon Life Sciences
17.14. Intas Pharmaceuticals
17.15. Invagen Pharmaceuticals
17.16. Jubilant Generics
17.17. Linux Laboratories
17.18. Lupin
17.19. Macleods Pharmaceuticals
17.20. MSN Laboratories
17.21. Sun Pharmaceutical Industries
17.22. Teva Pharmaceutical Industries
17.23. Torrent Pharmaceuticals
17.24. Zydus Pharmaceuticals
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Lurasidone Hydrochloride Generics Market, Years Considered for the Study
FIGURE 2. Global Lurasidone Hydrochloride Generics Market, Research Design
FIGURE 3. Global Lurasidone Hydrochloride Generics Market, Research Framework
FIGURE 4. Global Lurasidone Hydrochloride Generics Market, Data Triangulation
FIGURE 5. Global Lurasidone Hydrochloride Generics Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Lurasidone Hydrochloride Generics Market Size, by Form, 2025 vs 2032 (%)
FIGURE 7. Global Lurasidone Hydrochloride Generics Market Size, by Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Lurasidone Hydrochloride Generics Market Size, by Strength, 2025 vs 2032 (%)
FIGURE 9. Global Lurasidone Hydrochloride Generics Market Size, by Strength, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Lurasidone Hydrochloride Generics Market Size, by Packaging Type, 2025 vs 2032 (%)
FIGURE 11. Global Lurasidone Hydrochloride Generics Market Size, by Packaging Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Lurasidone Hydrochloride Generics Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Lurasidone Hydrochloride Generics Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Lurasidone Hydrochloride Generics Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Lurasidone Hydrochloride Generics Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Lurasidone Hydrochloride Generics Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Lurasidone Hydrochloride Generics Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Lurasidone Hydrochloride Generics Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Lurasidone Hydrochloride Generics Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Lurasidone Hydrochloride Generics Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Lurasidone Hydrochloride Generics Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Lurasidone Hydrochloride Generics Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Lurasidone Hydrochloride Generics Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Lurasidone Hydrochloride Generics Market Segmentation & Coverage
TABLE 2. Global Lurasidone Hydrochloride Generics Market Size, 2017-2032 (USD Million)
TABLE 3. Global Lurasidone Hydrochloride Generics Market Size, by Form, 2017-2032 (USD Million)
TABLE 4. Global Orally Disintegrating Tablet Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Orally Disintegrating Tablet Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Orally Disintegrating Tablet Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Tablet Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Tablet Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Tablet Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Lurasidone Hydrochloride Generics Market Size, by Strength, 2017-2032 (USD Million)
TABLE 11. Global 20 mg Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global 20 mg Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global 20 mg Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global 40 mg Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global 40 mg Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global 40 mg Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global 60 mg Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global 60 mg Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global 60 mg Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global 80 mg Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global 80 mg Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global 80 mg Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Lurasidone Hydrochloride Generics Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 24. Global Blister Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Blister Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Blister Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Bottle Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Bottle Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Bottle Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Lurasidone Hydrochloride Generics Market Size, by Application, 2017-2032 (USD Million)
TABLE 31. Global Bipolar Depression Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Bipolar Depression Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Bipolar Depression Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Major Depressive Disorder Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Major Depressive Disorder Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Major Depressive Disorder Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Schizophrenia Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Schizophrenia Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Schizophrenia Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Lurasidone Hydrochloride Generics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 41. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Lurasidone Hydrochloride Generics Market Size, by End User, 2017-2032 (USD Million)
TABLE 48. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Home Care Settings Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Home Care Settings Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Home Care Settings Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Lurasidone Hydrochloride Generics Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Asia-Pacific Lurasidone Hydrochloride Generics Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Asia-Pacific Lurasidone Hydrochloride Generics Market Size, by Form, 2017-2032 (USD Million)
TABLE 60. Asia-Pacific Lurasidone Hydrochloride Generics Market Size, by Strength, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Lurasidone Hydrochloride Generics Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Lurasidone Hydrochloride Generics Market Size, by Application, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Lurasidone Hydrochloride Generics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Lurasidone Hydrochloride Generics Market Size, by End User, 2017-2032 (USD Million)
TABLE 65. North America Lurasidone Hydrochloride Generics Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. North America Lurasidone Hydrochloride Generics Market Size, by Form, 2017-2032 (USD Million)
TABLE 67. North America Lurasidone Hydrochloride Generics Market Size, by Strength, 2017-2032 (USD Million)
TABLE 68. North America Lurasidone Hydrochloride Generics Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 69. North America Lurasidone Hydrochloride Generics Market Size, by Application, 2017-2032 (USD Million)
TABLE 70. North America Lurasidone Hydrochloride Generics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 71. North America Lurasidone Hydrochloride Generics Market Size, by End User, 2017-2032 (USD Million)
TABLE 72. Latin America Lurasidone Hydrochloride Generics Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Latin America Lurasidone Hydrochloride Generics Market Size, by Form, 2017-2032 (USD Million)
TABLE 74. Latin America Lurasidone Hydrochloride Generics Market Size, by Strength, 2017-2032 (USD Million)
TABLE 75. Latin America Lurasidone Hydrochloride Generics Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 76. Latin America Lurasidone Hydrochloride Generics Market Size, by Application, 2017-2032 (USD Million)
TABLE 77. Latin America Lurasidone Hydrochloride Generics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 78. Latin America Lurasidone Hydrochloride Generics Market Size, by End User, 2017-2032 (USD Million)
TABLE 79. Europe Lurasidone Hydrochloride Generics Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Europe Lurasidone Hydrochloride Generics Market Size, by Form, 2017-2032 (USD Million)
TABLE 81. Europe Lurasidone Hydrochloride Generics Market Size, by Strength, 2017-2032 (USD Million)
TABLE 82. Europe Lurasidone Hydrochloride Generics Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 83. Europe Lurasidone Hydrochloride Generics Market Size, by Application, 2017-2032 (USD Million)
TABLE 84. Europe Lurasidone Hydrochloride Generics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 85. Europe Lurasidone Hydrochloride Generics Market Size, by End User, 2017-2032 (USD Million)
TABLE 86. Middle East Lurasidone Hydrochloride Generics Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Middle East Lurasidone Hydrochloride Generics Market Size, by Form, 2017-2032 (USD Million)
TABLE 88. Middle East Lurasidone Hydrochloride Generics Market Size, by Strength, 2017-2032 (USD Million)
TABLE 89. Middle East Lurasidone Hydrochloride Generics Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 90. Middle East Lurasidone Hydrochloride Generics Market Size, by Application, 2017-2032 (USD Million)
TABLE 91. Middle East Lurasidone Hydrochloride Generics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 92. Middle East Lurasidone Hydrochloride Generics Market Size, by End User, 2017-2032 (USD Million)
TABLE 93. Africa Lurasidone Hydrochloride Generics Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Africa Lurasidone Hydrochloride Generics Market Size, by Form, 2017-2032 (USD Million)
TABLE 95. Africa Lurasidone Hydrochloride Generics Market Size, by Strength, 2017-2032 (USD Million)
TABLE 96. Africa Lurasidone Hydrochloride Generics Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 97. Africa Lurasidone Hydrochloride Generics Market Size, by Application, 2017-2032 (USD Million)
TABLE 98. Africa Lurasidone Hydrochloride Generics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 99. Africa Lurasidone Hydrochloride Generics Market Size, by End User, 2017-2032 (USD Million)
TABLE 100. Global Lurasidone Hydrochloride Generics Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. ASEAN Lurasidone Hydrochloride Generics Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. ASEAN Lurasidone Hydrochloride Generics Market Size, by Form, 2017-2032 (USD Million)
TABLE 103. ASEAN Lurasidone Hydrochloride Generics Market Size, by Strength, 2017-2032 (USD Million)
TABLE 104. ASEAN Lurasidone Hydrochloride Generics Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 105. ASEAN Lurasidone Hydrochloride Generics Market Size, by Application, 2017-2032 (USD Million)
TABLE 106. ASEAN Lurasidone Hydrochloride Generics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 107. ASEAN Lurasidone Hydrochloride Generics Market Size, by End User, 2017-2032 (USD Million)
TABLE 108. GCC Lurasidone Hydrochloride Generics Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. GCC Lurasidone Hydrochloride Generics Market Size, by Form, 2017-2032 (USD Million)
TABLE 110. GCC Lurasidone Hydrochloride Generics Market Size, by Strength, 2017-2032 (USD Million)
TABLE 111. GCC Lurasidone Hydrochloride Generics Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 112. GCC Lurasidone Hydrochloride Generics Market Size, by Application, 2017-2032 (USD Million)
TABLE 113. GCC Lurasidone Hydrochloride Generics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 114. GCC Lurasidone Hydrochloride Generics Market Size, by End User, 2017-2032 (USD Million)
TABLE 115. European Union Lurasidone Hydrochloride Generics Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. European Union Lurasidone Hydrochloride Generics Market Size, by Form, 2017-2032 (USD Million)
TABLE 117. European Union Lurasidone Hydrochloride Generics Market Size, by Strength, 2017-2032 (USD Million)
TABLE 118. European Union Lurasidone Hydrochloride Generics Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 119. European Union Lurasidone Hydrochloride Generics Market Size, by Application, 2017-2032 (USD Million)
TABLE 120. European Union Lurasidone Hydrochloride Generics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 121. European Union Lurasidone Hydrochloride Generics Market Size, by End User, 2017-2032 (USD Million)
TABLE 122. BRICS Lurasidone Hydrochloride Generics Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. BRICS Lurasidone Hydrochloride Generics Market Size, by Form, 2017-2032 (USD Million)
TABLE 124. BRICS Lurasidone Hydrochloride Generics Market Size, by Strength, 2017-2032 (USD Million)
TABLE 125. BRICS Lurasidone Hydrochloride Generics Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 126. BRICS Lurasidone Hydrochloride Generics Market Size, by Application, 2017-2032 (USD Million)
TABLE 127. BRICS Lurasidone Hydrochloride Generics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 128. BRICS Lurasidone Hydrochloride Generics Market Size, by End User, 2017-2032 (USD Million)
TABLE 129. G7 Lurasidone Hydrochloride Generics Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. G7 Lurasidone Hydrochloride Generics Market Size, by Form, 2017-2032 (USD Million)
TABLE 131. G7 Lurasidone Hydrochloride Generics Market Size, by Strength, 2017-2032 (USD Million)
TABLE 132. G7 Lurasidone Hydrochloride Generics Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 133. G7 Lurasidone Hydrochloride Generics Market Size, by Application, 2017-2032 (USD Million)
TABLE 134. G7 Lurasidone Hydrochloride Generics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 135. G7 Lurasidone Hydrochloride Generics Market Size, by End User, 2017-2032 (USD Million)
TABLE 136. NATO Lurasidone Hydrochloride Generics Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. NATO Lurasidone Hydrochloride Generics Market Size, by Form, 2017-2032 (USD Million)
TABLE 138. NATO Lurasidone Hydrochloride Generics Market Size, by Strength, 2017-2032 (USD Million)
TABLE 139. NATO Lurasidone Hydrochloride Generics Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 140. NATO Lurasidone Hydrochloride Generics Market Size, by Application, 2017-2032 (USD Million)
TABLE 141. NATO Lurasidone Hydrochloride Generics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 142. NATO Lurasidone Hydrochloride Generics Market Size, by End User, 2017-2032 (USD Million)
TABLE 143. Global Lurasidone Hydrochloride Generics Market Size, by Country, 2017-2032 (USD Million)
TABLE 144. United States Lurasidone Hydrochloride Generics Market Size, 2017-2032 (USD Million)
TABLE 145. United States Lurasidone Hydrochloride Generics Market Size, by Form, 2017-2032 (USD Million)
TABLE 146. United States Lurasidone Hydrochloride Generics Market Size, by Strength, 2017-2032 (USD Million)
TABLE 147. United States Lurasidone Hydrochloride Generics Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 148. United States Lurasidone Hydrochloride Generics Market Size, by Application, 2017-2032 (USD Million)
TABLE 149. United States Lurasidone Hydrochloride Generics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 150. United States Lurasidone Hydrochloride Generics Market Size, by End User, 2017-2032 (USD Million)
TABLE 151. Canada Lurasidone Hydrochloride Generics Market Size, 2017-2032 (USD Million)
TABLE 152. Canada Lurasidone Hydrochloride Generics Market Size, by Form, 2017-2032 (USD Million)
TABLE 153. Canada Lurasidone Hydrochloride Generics Market Size, by Strength, 2017-2032 (USD Million)
TABLE 154. Canada Lurasidone Hydrochloride Generics Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 155. Canada Lurasidone Hydrochloride Generics Market Size, by Application, 2017-2032 (USD Million)
TABLE 156. Canada Lurasidone Hydrochloride Generics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 157. Canada Lurasidone Hydrochloride Generics Market Size, by End User, 2017-2032 (USD Million)
TABLE 158. Mexico Lurasidone Hydrochloride Generics Market Size, 2017-2032 (USD Million)
TABLE 159. Mexico Lurasidone Hydrochloride Generics Market Size, by Form, 2017-2032 (USD Million)
TABLE 160. Mexico Lurasidone Hydrochloride Generics Market Size, by Strength, 2017-2032 (USD Million)
TABLE 161. Mexico Lurasidone Hydrochloride Generics Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 162. Mexico Lurasidone Hydrochloride Generics Market Size, by Application, 2017-2032 (USD Million)
TABLE 163. Mexico Lurasidone Hydrochloride Generics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 164. Mexico Lurasidone Hydrochloride Generics Market Size, by End User, 2017-2032 (USD Million)
TABLE 165. Brazil Lurasidone Hydrochloride Generics Market Size, 2017-2032 (USD Million)
TABLE 166. Brazil Lurasidone Hydrochloride Generics Market Size, by Form, 2017-2032 (USD Million)
TABLE 167. Brazil Lurasidone Hydrochloride Generics Market Size, by Strength, 2017-2032 (USD Million)
TABLE 168. Brazil Lurasidone Hydrochloride Generics Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 169. Brazil Lurasidone Hydrochloride Generics Market Size, by Application, 2017-2032 (USD Million)
TABLE 170. Brazil Lurasidone Hydrochloride Generics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 171. Brazil Lurasidone Hydrochloride Generics Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. United Kingdom Lurasidone Hydrochloride Generics Market Size, 2017-2032 (USD Million)
TABLE 173. United Kingdom Lurasidone Hydrochloride Generics Market Size, by Form, 2017-2032 (USD Million)
TABLE 174. United Kingdom Lurasidone Hydrochloride Generics Market Size, by Strength, 2017-2032 (USD Million)
TABLE 175. United Kingdom Lurasidone Hydrochloride Generics Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 176. United Kingdom Lurasidone Hydrochloride Generics Market Size, by Application, 2017-2032 (USD Million)
TABLE 177. United Kingdom Lurasidone Hydrochloride Generics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 178. United Kingdom Lurasidone Hydrochloride Generics Market Size, by End User, 2017-2032 (USD Million)
TABLE 179. Germany Lurasidone Hydrochloride Generics Market Size, 2017-2032 (USD Million)
TABLE 180. Germany Lurasidone Hydrochloride Generics Market Size, by Form, 2017-2032 (USD Million)
TABLE 181. Germany Lurasidone Hydrochloride Generics Market Size, by Strength, 2017-2032 (USD Million)
TABLE 182. Germany Lurasidone Hydrochloride Generics Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 183. Germany Lurasidone Hydrochloride Generics Market Size, by Application, 2017-2032 (USD Million)
TABLE 184. Germany Lurasidone Hydrochloride Generics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 185. Germany Lurasidone Hydrochloride Generics Market Size, by End User, 2017-2032 (USD Million)
TABLE 186. France Lurasidone Hydrochloride Generics Market Size, 2017-2032 (USD Million)
TABLE 187. France Lurasidone Hydrochloride Generics Market Size, by Form, 2017-2032 (USD Million)
TABLE 188. France Lurasidone Hydrochloride Generics Market Size, by Strength, 2017-2032 (USD Million)
TABLE 189. France Lurasidone Hydrochloride Generics Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 190. France Lurasidone Hydrochloride Generics Market Size, by Application, 2017-2032 (USD Million)
TABLE 191. France Lurasidone Hydrochloride Generics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 192. France Lurasidone Hydrochloride Generics Market Size, by End User, 2017-2032 (USD Million)
TABLE 193. Russia Lurasidone Hydrochloride Generics Market Size, 2017-2032 (USD Million)
TABLE 194. Russia Lurasidone Hydrochloride Generics Market Size, by Form, 2017-2032 (USD Million)
TABLE 195. Russia Lurasidone Hydrochloride Generics Market Size, by Strength, 2017-2032 (USD Million)
TABLE 196. Russia Lurasidone Hydrochloride Generics Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 197. Russia Lurasidone Hydrochloride Generics Market Size, by Application, 2017-2032 (USD Million)
TABLE 198. Russia Lurasidone Hydrochloride Generics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 199. Russia Lurasidone Hydrochloride Generics Market Size, by End User, 2017-2032 (USD Million)
TABLE 200. Italy Lurasidone Hydrochloride Generics Market Size, 2017-2032 (USD Million)
TABLE 201. Italy Lurasidone Hydrochloride Generics Market Size, by Form, 2017-2032 (USD Million)
TABLE 202. Italy Lurasidone Hydrochloride Generics Market Size, by Strength, 2017-2032 (USD Million)
TABLE 203. Italy Lurasidone Hydrochloride Generics Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 204. Italy Lurasidone Hydrochloride Generics Market Size, by Application, 2017-2032 (USD Million)
TABLE 205. Italy Lurasidone Hydrochloride Generics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 206. Italy Lurasidone Hydrochloride Generics Market Size, by End User, 2017-2032 (USD Million)
TABLE 207. Spain Lurasidone Hydrochloride Generics Market Size, 2017-2032 (USD Million)
TABLE 208. Spain Lurasidone Hydrochloride Generics Market Size, by Form, 2017-2032 (USD Million)
TABLE 209. Spain Lurasidone Hydrochloride Generics Market Size, by Strength, 2017-2032 (USD Million)
TABLE 210. Spain Lurasidone Hydrochloride Generics Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 211. Spain Lurasidone Hydrochloride Generics Market Size, by Application, 2017-2032 (USD Million)
TABLE 212. Spain Lurasidone Hydrochloride Generics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 213. Spain Lurasidone Hydrochloride Generics Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. China Lurasidone Hydrochloride Generics Market Size, 2017-2032 (USD Million)
TABLE 215. China Lurasidone Hydrochloride Generics Market Size, by Form, 2017-2032 (USD Million)
TABLE 216. China Lurasidone Hydrochloride Generics Market Size, by Strength, 2017-2032 (USD Million)
TABLE 217. China Lurasidone Hydrochloride Generics Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 218. China Lurasidone Hydrochloride Generics Market Size, by Application, 2017-2032 (USD Million)
TABLE 219. China Lurasidone Hydrochloride Generics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 220. China Lurasidone Hydrochloride Generics Market Size, by End User, 2017-2032 (USD Million)
TABLE 221. India Lurasidone Hydrochloride Generics Market Size, 2017-2032 (USD Million)
TABLE 222. India Lurasidone Hydrochloride Generics Market Size, by Form, 2017-2032 (USD Million)
TABLE 223. India Lurasidone Hydrochloride Generics Market Size, by Strength, 2017-2032 (USD Million)
TABLE 224. India Lurasidone Hydrochloride Generics Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 225. India Lurasidone Hydrochloride Generics Market Size, by Application, 2017-2032 (USD Million)
TABLE 226. India Lurasidone Hydrochloride Generics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 227. India Lurasidone Hydrochloride Generics Market Size, by End User, 2017-2032 (USD Million)
TABLE 228. Japan Lurasidone Hydrochloride Generics Market Size, 2017-2032 (USD Million)
TABLE 229. Japan Lurasidone Hydrochloride Generics Market Size, by Form, 2017-2032 (USD Million)
TABLE 230. Japan Lurasidone Hydrochloride Generics Market Size, by Strength, 2017-2032 (USD Million)
TABLE 231. Japan Lurasidone Hydrochloride Generics Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 232. Japan Lurasidone Hydrochloride Generics Market Size, by Application, 2017-2032 (USD Million)
TABLE 233. Japan Lurasidone Hydrochloride Generics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 234. Japan Lurasidone Hydrochloride Generics Market Size, by End User, 2017-2032 (USD Million)
TABLE 235. Australia Lurasidone Hydrochloride Generics Market Size, 2017-2032 (USD Million)
TABLE 236. Australia Lurasidone Hydrochloride Generics Market Size, by Form, 2017-2032 (USD Million)
TABLE 237. Australia Lurasidone Hydrochloride Generics Market Size, by Strength, 2017-2032 (USD Million)
TABLE 238. Australia Lurasidone Hydrochloride Generics Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 239. Australia Lurasidone Hydrochloride Generics Market Size, by Application, 2017-2032 (USD Million)
TABLE 240. Australia Lurasidone Hydrochloride Generics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 241. Australia Lurasidone Hydrochloride Generics Market Size, by End User, 2017-2032 (USD Million)
TABLE 242. South Korea Lurasidone Hydrochloride Generics Market Size, 2017-2032 (USD Million)
TABLE 243. South Korea Lurasidone Hydrochloride Generics Market Size, by Form, 2017-2032 (USD Million)
TABLE 244. South Korea Lurasidone Hydrochloride Generics Market Size, by Strength, 2017-2032 (USD Million)
TABLE 245. South Korea Lurasidone Hydrochloride Generics Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 246. South Korea Lurasidone Hydrochloride Generics Market Size, by Application, 2017-2032 (USD Million)
TABLE 247. South Korea Lurasidone Hydrochloride Generics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 248. South Korea Lurasidone Hydrochloride Generics Market Size, by End User, 2017-2032 (USD Million)
TABLE 249. Global Lurasidone Hydrochloride Generics Market Share, by Key Player, 2025
TABLE 250. Global Lurasidone Hydrochloride Generics Market, Key Experts

Companies Mentioned

  • Accord Healthcare
  • Alembic Pharmaceuticals
  • Alkem Laboratories
  • Amneal Pharmaceuticals
  • Annora Pharma
  • Aurobindo Pharma
  • Camber Pharmaceuticals
  • Chartwell Rx
  • Cipla
  • Dr. Reddy's Laboratories
  • Emcure Pharmaceuticals
  • Heritage Pharma Avet
  • Icon Life Sciences
  • Intas Pharmaceuticals
  • Invagen Pharmaceuticals
  • Jubilant Generics
  • Linux Laboratories
  • Lupin
  • Macleods Pharmaceuticals
  • MSN Laboratories
  • Sun Pharmaceutical Industries
  • Teva Pharmaceutical Industries
  • Torrent Pharmaceuticals
  • Zydus Pharmaceuticals

Related Topics

Related Reports

Lurasidone (CAS 367514-87-2) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Lurasidone (CAS 367514-87-2) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Antipsychotic Drugs Market - Global Forecast 2026-2032 - Product Image

Antipsychotic Drugs Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Ziprasidone Hydrochloride Capsules Market - Global Forecast 2026-2032 - Product Image

Ziprasidone Hydrochloride Capsules Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Antipsychotic Drugs Market Report 2026 - Product Image

Antipsychotic Drugs Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Schizophrenia Drugs Market Report by Treatment, Therapeutic Class, Distribution Channel, Country and Company Analysis 2026-2034 - Product Image

Schizophrenia Drugs Market Report by Treatment, Therapeutic Class, Distribution Channel, Country and Company Analysis 2026-2034

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.